medicine-news-1/epygi-technologies-partners-with-faxback-to-incorporate-microsoft-fax-into-epygi-26apos-3bs-voip-phone-systems-55964-4/;msg18067;topicseen

Breaking Biology Technology:NIST researchers put a new spin on atomic musical chairs 2 Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2 Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2 Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3 Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2 Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3 Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4 Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5

[0] NIST researchers put a new spin on atomic musical chairs [0] Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)[0] Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope [0] Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced

Breaking Medicine Technology:Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 2 Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 3 Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 4 Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 5 New FDA Approved Breast Cancer Screening Tool 2 New FDA Approved Breast Cancer Screening Tool 3 European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2 Study to Investigate AHCC and the Swine Flu Virus 47555 1 Study to Investigate AHCC and the Swine Flu Virus 47555 2 Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 1 Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 2 Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 3 Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 4 PROTECT 1 Phase II III Induction Stage Results for ChemoCentryxs Traficet EN 28TM 29 Presented in Oral Session at DDW 2009 Conference 4508 1 PROTECT 1 Phase II III Induction Stage Results for ChemoCentryxs Traficet EN 28TM 29 Presented in Oral Session at DDW 2009 Conference 4508 2 PROTECT 1 Phase II III Induction Stage Results for ChemoCentryxs Traficet EN 28TM 29 Presented in Oral Session at DDW 2009 Conference 4508 3 PROTECT 1 Phase II III Induction Stage Results for ChemoCentryxs Traficet EN 28TM 29 Presented in Oral Session at DDW 2009 Conference 4508 4 PROTECT 1 Phase II III Induction Stage Results for ChemoCentryxs Traficet EN 28TM 29 Presented in Oral Session at DDW 2009 Conference 4508 5 PROTECT 1 Phase II III Induction Stage Results for ChemoCentryxs Traficet EN 28TM 29 Presented in Oral Session at DDW 2009 Conference 4508 6

[0] Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine [0] New FDA Approved Breast Cancer Screening Tool [0] European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis